Utilization of Next-Generation Sequencing (NGS) in Unexplained Cytopenia
Authors:
- Zohre SadeghianZSZohre Sadeghian
- Kirill A. LyapichevKLKirill A. Lyapichev
- Mark J. ChenMCMark J. Chen
- Maria J. DiacovoMDMaria J. Diacovo
- Chakra ChaulagainCCChakra Chaulagain
- Chieh-Lin FuCFChieh-Lin Fu
- David S. BoslerDBDavid S. Bosler
- Amir BehdadABAmir Behdad
Open Access
- 21 August 2026
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 28 (11) , 859-870
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Prediction of Risk for Myeloid Malignancy in Clonal HematopoiesisNEJM Evidence, 2023
- The new WHO and ICC classification systems for myelodysplastic syndromes and their impact on the clinical laboratoryJournal of Hematopathology, 2023
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsLeukemia, 2022
- Clinical Applications and Utility of a Precision Medicine Approach for Patients With Unexplained CytopeniasMayo Clinic Proceedings, 2019
- The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopeniaAmerican Journal of Hematology, 2019
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in CancerThe Journal of Molecular Diagnostics, 2017
- Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changesAmerican Journal of Hematology, 2016
- Bone marrow evaluation in new-onset pancytopeniaHuman Pathology, 2013
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- Myelodysplastic syndromesCancer, 2007